Artivion Inc Total Liabilities
Artivion Inc total liabilities. Based on the latest financial reports, Artivion Inc (AORT) has total liabilities worth $626.35 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See AORT days of operational coverage to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Artivion Inc (1991–2025)
Total liabilities of Artivion Inc from 1991 to 2025. This chart illustrates how Artivion Inc's total liabilities have evolved over time, based on quarterly financial data. Check Artivion Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Artivion Inc Competitors by Total Liabilities
The table below lists competitors of Artivion Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ina Invest Holding AG
SW:INA
|
Switzerland | CHF479.89 Million |
|
U Blox Holding AG
SW:UBXN
|
Switzerland | CHF104.73 Million |
|
Zhongli Science and Technology Group Co Ltd
SHE:002309
|
China | CN¥2.91 Billion |
|
Deluxe Corporation
NYSE:DLX
|
USA | $1.86 Billion |
|
Bangkok Chain Hospital Public Company Limited
BK:BCH-R
|
Thailand | ฿3.43 Billion |
|
Blue Square Real Estate Ltd
TA:BLSR
|
Israel | ILA8.21 Billion |
|
Weibo Corporation
F:2WBA
|
Germany | €3.08 Billion |
|
Parksystems Corp
KQ:140860
|
Korea | ₩104.85 Billion |
Liability Composition Analysis (1991–2025)
This chart breaks down Artivion Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see AORT total assets.
Liquidity & Leverage Metrics
Artivion Inc Total Liabilities Ratios Explained
Artivion Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Artivion Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Artivion Inc (1991–2025)
The table below shows the annual total liabilities of Artivion Inc from 1991 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $436.56 Million | -14.88% |
| 2024-12-31 | $512.90 Million | +0.45% |
| 2023-12-31 | $510.62 Million | +6.72% |
| 2022-12-31 | $478.47 Million | -2.81% |
| 2021-12-31 | $492.32 Million | +6.87% |
| 2020-12-31 | $460.69 Million | +43.98% |
| 2019-12-31 | $319.96 Million | +8.09% |
| 2018-12-31 | $296.02 Million | -5.31% |
| 2017-12-31 | $312.63 Million | +191.75% |
| 2016-12-31 | $107.16 Million | +313.29% |
| 2015-12-31 | $25.93 Million | -5.62% |
| 2014-12-31 | $27.47 Million | -8.23% |
| 2013-12-31 | $29.94 Million | +3.07% |
| 2012-12-31 | $29.04 Million | +10.32% |
| 2011-12-31 | $26.33 Million | +12.04% |
| 2010-12-31 | $23.50 Million | +0.35% |
| 2009-12-31 | $23.41 Million | -12.21% |
| 2008-12-31 | $26.67 Million | -11.27% |
| 2007-12-31 | $30.06 Million | +8.21% |
| 2006-12-31 | $27.78 Million | +6.07% |
| 2005-12-31 | $26.19 Million | +10.96% |
| 2004-12-31 | $23.60 Million | -11.57% |
| 2003-12-31 | $26.69 Million | +0.28% |
| 2002-12-31 | $26.61 Million | -4.51% |
| 2001-12-31 | $27.87 Million | +23.25% |
| 2000-12-31 | $22.61 Million | +63.88% |
| 1999-12-31 | $13.80 Million | -23.34% |
| 1998-12-31 | $18.00 Million | -23.40% |
| 1997-12-31 | $23.50 Million | +132.67% |
| 1996-12-31 | $10.10 Million | +225.81% |
| 1995-12-31 | $3.10 Million | -11.43% |
| 1994-12-31 | $3.50 Million | 0.00% |
| 1993-12-31 | $3.50 Million | -31.37% |
| 1992-12-31 | $5.10 Million | +18.60% |
| 1991-12-31 | $4.30 Million | -- |
About Artivion Inc
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid… Read more